Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Putter

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Breast Cancer Research and Treatment|January 25, 2015
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysisC C Engels, A Charehbili, C J H van de Velde, et al.
Journal of Sex & Marital Therapy|November 26, 2019
Sexual Health Needs: How Do Breast Cancer Patients and Their Partners Want Information?L F Albers, G F Van Ek, E M Krouwel, et al.
Ebiomedicine|April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trialK Hoyer, R Hablesreiter, Y Inoue, et al.
British Journal of Cancer|October 5, 2013
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trialJ M S Bartlett, C L Brookes, T Piper, et al.
Breast Cancer Research and Treatment|July 12, 2013
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trialV O Dezentjé, R H N van Schaik, J M Vletter-Bogaartz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2014
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients--a phase II trialDuveken B Y Fontein, Ayoub Charehbili, Johan W R Nortier, et al.
The British Journal of Surgery|November 27, 2012
Differences in outcomes of oesophageal and gastric cancer surgery across EuropeJ L Dikken, J W van Sandick, W H Allum, et al.
Breast (Edinburgh, Scotland)|November 29, 2015
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)A Charehbili, N A T Hamdy, V T H B M Smit, et al.
The British Journal of Surgery|April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countriesJ G H van Nes, C Seynaeve, S Jones, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 22, 2017
Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysisH J M Handgraaf, L S F Boogerd, D J Höppener, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Breast Cancer Research and Treatment|January 25, 2015
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysisC C Engels, A Charehbili, C J H van de Velde, et al.
Journal of Sex & Marital Therapy|November 26, 2019
Sexual Health Needs: How Do Breast Cancer Patients and Their Partners Want Information?L F Albers, G F Van Ek, E M Krouwel, et al.
Ebiomedicine|April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trialK Hoyer, R Hablesreiter, Y Inoue, et al.
British Journal of Cancer|October 5, 2013
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trialJ M S Bartlett, C L Brookes, T Piper, et al.
Breast Cancer Research and Treatment|July 12, 2013
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trialV O Dezentjé, R H N van Schaik, J M Vletter-Bogaartz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2014
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients--a phase II trialDuveken B Y Fontein, Ayoub Charehbili, Johan W R Nortier, et al.
The British Journal of Surgery|November 27, 2012
Differences in outcomes of oesophageal and gastric cancer surgery across EuropeJ L Dikken, J W van Sandick, W H Allum, et al.
Breast (Edinburgh, Scotland)|November 29, 2015
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)A Charehbili, N A T Hamdy, V T H B M Smit, et al.
The British Journal of Surgery|April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countriesJ G H van Nes, C Seynaeve, S Jones, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 22, 2017
Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysisH J M Handgraaf, L S F Boogerd, D J Höppener, et al.
Pageof 16